Barclays Trims Keurig Dr Pepper (KDP) Price Target, Maintains Overweight Rating

Keurig Dr Pepper Inc. (NASDAQ:KDP) is one of the Best Non-Mega Cap NASDAQ Stocks to Buy Right Now. Barclays has lowered its price target on Keurig Dr Pepper Inc. (NASDAQ:KDP) to $37 from $38, while maintaining an Overweight rating on the stock. The revision follows a series of investor meetings with company management, during which Barclays updated its financial model based on new insights.

Barclays Trims Keurig Dr Pepper (KDP) Price Target, Maintaining Overweight Rating

A conveyor belt filled with assorted K-Cup pods, ready for packaging.

Though the price target adjustment is modest, it reflects a recalibration of near-term expectations rather than a shift in overall outlook. The firm continues to view Keurig Dr Pepper Inc. (NASDAQ:KDP) as well-positioned within the beverage sector, citing stable fundamentals and a balanced portfolio spanning both hot and cold drink categories.

Barclays noted that management remains focused on execution, particularly around pricing strategies, innovation, and supply chain efficiency. While certain category pressures persist, especially in the face of changing consumer preferences and cost sensitivities, the company has shown an ability to adapt and protect margins.

The updated model incorporates refined assumptions around volume trends and promotional activity, with Barclays anticipating steady performance but acknowledging a more competitive environment. Despite trimming the target, the firm sees potential for upside, supported by brand strength and disciplined capital deployment.

Keurig Dr Pepper shares were little changed in Monday trading, as investors weighed the revised outlook against broader market conditions and sector-specific headwinds.

While we acknowledge the potential of KDP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than KDP and that has a 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: Top 10 Healthcare AI Stocks to Buy According to Hedge Funds and 10 Consumer Defensive Stocks to Buy Now.

Disclosure: None. This article is originally published at Insider Monkey.